{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:59:44Z","timestamp":1790780384926,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.clim.2021.108817","type":"journal-article","created":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T05:41:08Z","timestamp":1627969268000},"page":"108817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Assessment of commonly used methods to determine myelin-reactivity of T cells in multiple sclerosis"],"prefix":"10.1016","volume":"230","author":[{"given":"Marina Rode","family":"von Essen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilie","family":"Ammitzb\u00f8ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"B\u00f6rnsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Sellebjerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2021.108817_bb0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-0036-1579739","article-title":"Immunology of multiple sclerosis","volume":"36","author":"Sospedra","year":"2016","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.clim.2021.108817_bb0010","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.neuron.2018.01.021","article-title":"Multiple sclerosis: mechanisms and immunotherapy","volume":"97","author":"Baecher-Allan","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.clim.2021.108817_bb0015","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple Sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2021.108817_bb0020","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1474-4422(15)00334-8","article-title":"The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets","volume":"15","author":"Hohlfeld","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2021.108817_bb0025","first-page":"317","article-title":"The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells","volume":"15","author":"Hohlfeld","year":"2016","journal-title":"B cells, and antibodies in the focus of reverse-translational research, Lancet Neurol"},{"key":"10.1016\/j.clim.2021.108817_bb0030","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.4049\/jimmunol.1001543","article-title":"Increased frequencies of myelin oligodendrocyte glycoprotein\/MHC class II-binding CD4 cells in patients with multiple sclerosis","volume":"187","author":"Raddassi","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2021.108817_bb0035","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/awq074","article-title":"T cell recognition of self-antigen presenting cells by protein transfer assay reveals a high frequency of anti-myelin T cells in multiple sclerosis","volume":"133","author":"Bahbouhi","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.clim.2021.108817_bb0040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0165-5728(92)90095-3","article-title":"Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis","volume":"38","author":"Chou","year":"1992","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2021.108817_bb0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2567.2008.02837.x","article-title":"T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis","volume":"125","author":"Hedegaard","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.clim.2021.108817_bb0050","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.410420106","article-title":"Cytokine profile of myelin basic protein-reactive T cells in multiple sclerosis and healthy individuals","volume":"42","author":"Hermans","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2021.108817_bb0055","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1002\/(SICI)1521-4141(199810)28:10<3329::AID-IMMU3329>3.0.CO;2-B","article-title":"Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis","volume":"28","author":"Wallstr\u00f6m","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2021.108817_bb0060","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1468-1331.2002.00391.x","article-title":"Multiple MAG peptides are recognized by circulating T and B lymphocytes in polyneuropathy and multiple sclerosis","volume":"9","author":"Andersson","year":"2002","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clim.2021.108817_bb0065","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1172\/JCI114800","article-title":"Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma","volume":"86","author":"Olsson","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2021.108817_bb0070","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jneuroim.2006.06.010","article-title":"Phenotypic characterization of autoreactive T cells in multiple sclerosis","volume":"178","author":"Ratts","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2021.108817_bb0075","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.4049\/jimmunol.146.5.1490","article-title":"T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis","volume":"146","author":"Sun","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2021.108817_bb0080","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.4049\/jimmunol.165.3.1641","article-title":"Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine production","volume":"165","author":"Pelfrey","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2021.108817_bb0085","doi-asserted-by":"crossref","first-page":"8365","DOI":"10.4049\/jimmunol.175.12.8365","article-title":"CD8+ T cell-mediated HLA-A*0201-restricted cytotoxicity to transaldolase peptide 168-176 in patients with multiple sclerosis","volume":"175","author":"Niland","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2021.108817_bb0090","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jneuroim.2006.06.001","article-title":"CD28-CD57+ T cells predominate in CD8 responses to glatiramer acetate","volume":"178","author":"Ratts","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2021.108817_bb0095","doi-asserted-by":"crossref","unstructured":"Y. Cao, B.A. Goods, K. Raddassi, G.T. Nepom, W.W. Kwok, J.C. Love, et al., Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis, Sci Transl Med 7 (2015) 287ra274.","DOI":"10.1126\/scitranslmed.aaa8038"},{"key":"10.1016\/j.clim.2021.108817_bb0100","first-page":"203","article-title":"Unique gene expression patterns in human T-cell lines generated from multiple sclerosis patients by stimulation with a synthetic MOG peptide","volume":"12","author":"Mandel","year":"2005","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.clim.2021.108817_bb0105","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jneuroim.2010.05.025","article-title":"Memory CD4+CD127high T cells from patients with multiple sclerosis produce IL-17 in response to myelin antigens","volume":"226","author":"Venken","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2021.108817_bb0110","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/eji.200838023","article-title":"Blood CD8+ T cell responses against myelin determinants in multiple sclerosis and healthy individuals","volume":"38","author":"Berthelot","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2021.108817_bb0115","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4049\/jimmunol.139.1.68","article-title":"Myelin basic protein and proteolipid protein reactivity of brain- and cerebrospinal fluid-derived T cell clones in multiple sclerosis and postinfectious encephalomyelitis","volume":"139","author":"Hafler","year":"1987","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2021.108817_bb0120","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/ana.410320305","article-title":"Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity","volume":"32","author":"Jingwu","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2021.108817_bb0125","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10072-012-1144-4","article-title":"MOBP-specific cellular immune responses are weaker than MOG-specific cellular immune responses in patients with multiple sclerosis and healthy subjects","volume":"34","author":"Jilek","year":"2013","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.clim.2021.108817_bb0130","doi-asserted-by":"crossref","unstructured":"N. Hellings, M. Bar\u00e9e, C. Verhoeven, B. D'Hooghe M, R. Medaer, C.C. Bernard, et al., T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls, J Neurosci Res 63 (2001) 290\u2013302.","DOI":"10.1002\/1097-4547(20010201)63:3<290::AID-JNR1023>3.0.CO;2-4"},{"key":"10.1016\/j.clim.2021.108817_bb0135","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1084\/jem.179.3.973","article-title":"Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis","volume":"179","author":"Zhang","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2021.108817_bb0140","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/1521-4141(200103)31:3<907::AID-IMMU907>3.0.CO;2-1","article-title":"Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals","volume":"31","author":"Tejada-Simon","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2021.108817_bb0145","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2021.108817_bb0150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2021.108817_bb0155","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0165-5728(03)00048-1","article-title":"Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controls","volume":"137","author":"Van der Aa","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2021.108817_bb0160","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2021.108817_bb0165","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1021\/pr201196e","article-title":"Myelin basic protein undergoes a broader range of modifications in mammals than in lower vertebrates","volume":"11","author":"Zhang","year":"2012","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.clim.2021.108817_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2016.11.008","article-title":"Nitration of MOG diminishes its encephalitogenicity depending on MHC haplotype","volume":"303","author":"Warnecke","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2021.108817_bb0175","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/1531-8249(199901)45:1<33::AID-ART7>3.0.CO;2-G","article-title":"Isolation of myelin basic protein-specific T cells predominantly from the memory T-cell compartment in multiple sclerosis","volume":"45","author":"Burns","year":"1999","journal-title":"Ann. Neurol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661621001546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661621001546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:03:49Z","timestamp":1761494629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661621001546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":35,"alternative-id":["S1521661621001546"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2021.108817","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of commonly used methods to determine myelin-reactivity of T cells in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2021.108817","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108817"}}